Drug intelligence / Profile preview

seasonal influenza vaccine, split virion, inactivated, vero cell-derived

Development stage
Unknown
Lead developer
Takeda
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**Split virion, inactivated seasonal influenza vaccine (Vero cell-derived)** is a trivalent, non-adjuvanted vaccine intended for active immunization against influenza, formulated for seasonal use. It contains split and purified influenza virus antigens (A/H1N1, A/H3N2, B) produced in Vero cells (a continuous mammalian cell line derived from African green monkey kidney), inactivated by formaldehyde and UV, and purified using sucrose gradient. Its mechanism of action is to induce specific immunity against the included influenza virus strains by generating neutralizing antibodies targeting the viral hemagglutinin proteins, thus conferring protection against influenza disease. This Vero cell-based platform avoids the use of eggs, allowing rapid scale-up and high purity formulations, particularly beneficial for individuals allergic to egg proteins or in times of pandemic preparedness. Immunogenicity and safety have been demonstrated in adult and elderly populations[1][3][4].

Brand names
Preflucel Flucelvax TrivalentFlucelvax Trivalent
Other names
inactivated split virus seasonal influenza vaccine (vero cell-derived)
02

Targets

HA (Hemagglutinin)H3 HA (Influenza A hemagglutinin H3)

Beyond the preview

Go deeper on seasonal influenza vaccine, split virion, inactivated, vero cell-derived.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on seasonal influenza vaccine, split virion, inactivated, vero cell-derived.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call